{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:46:51Z","timestamp":1782776811595,"version":"3.54.5"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejogrb.2026.115048","type":"journal-article","created":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T14:59:28Z","timestamp":1772377168000},"page":"115048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Metformin: An emerging therapeutic approach for prevention and treatment of preeclampsia"],"prefix":"10.1016","volume":"321","author":[{"given":"Sher","family":"Afghan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huma","family":"Quasimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Iqbal","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2026.115048_b0005","doi-asserted-by":"crossref","unstructured":"C.W. Redman, I.L. Sargent, Latest advances in understanding preeclampsia, 2005. doi: 10.1126\/science.1111726.","DOI":"10.1126\/science.1111726"},{"issue":"9461","key":"10.1016\/j.ejogrb.2026.115048_b0010","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)17987-2","article-title":"Pre-eclampsia","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2026.115048_b0015","article-title":"Preeclampsia\u2014pathophysiology and clinical presentations","author":"Ives","year":"2020","journal-title":"JACC State-of-the-Art Review"},{"issue":"6","key":"10.1016\/j.ejogrb.2026.115048_b0020","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3390\/biom10060953","article-title":"Pathogenesis of preeclampsia and therapeutic approaches targeting the placenta","volume":"10","author":"Jena","year":"2020","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.ejogrb.2026.115048_b0025","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.3390\/ijms25084532","article-title":"The pathophysiological, genetic, and hormonal changes in preeclampsia: a systematic review of the molecular mechanisms","volume":"25","author":"Chiang","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"22","key":"10.1016\/j.ejogrb.2026.115048_b0030","doi-asserted-by":"crossref","first-page":"12195","DOI":"10.3390\/ijms252212195","article-title":"Oxidative stress and placental pathogenesis: a contemporary overview of potential biomarkers and emerging therapeutics","volume":"25","author":"Vornic","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115048_b0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia","volume":"9","author":"Dimitriadis","year":"2023","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.ejogrb.2026.115048_b0040","doi-asserted-by":"crossref","unstructured":"S Tong, TJ Kaitu\u2019u-Lino, R Hastie, F Brownfoot, C Cluver, N Hannan, Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: new horizons for the prevention or treatment of preeclampsia, 2022. doi: 10.1016\/j.ajog.2020.09.014.","DOI":"10.1016\/j.ajog.2020.09.014"},{"key":"10.1016\/j.ejogrb.2026.115048_b0045","doi-asserted-by":"crossref","unstructured":"YW Wang et al., Metformin: a review of its potential indications, 2017. doi: 10.2147\/DDDT.S141675.","DOI":"10.2147\/DDDT.S141675"},{"key":"10.1016\/j.ejogrb.2026.115048_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.placenta.2013.12.008","article-title":"IFPA senior award lecture: making sense of pre-eclampsia - two placental causes of preeclampsia?","author":"Redman","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.ejogrb.2026.115048_b0055","doi-asserted-by":"crossref","DOI":"10.1172\/JCI70431","article-title":"Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state","author":"Romero","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejogrb.2026.115048_b0060","doi-asserted-by":"crossref","unstructured":"AC Palei, FT Spradley, JP Warrington, EM George, JP Granger, Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology, 2013. doi: 10.1111\/apha.12106.","DOI":"10.1111\/apha.12106"},{"key":"10.1016\/j.ejogrb.2026.115048_b0065","doi-asserted-by":"crossref","unstructured":"B Huppertz, Placental origins of preeclampsia: challenging the current hypothesis, 2008. doi: 10.1161\/HYPERTENSIONAHA.107.107607.","DOI":"10.1161\/HYPERTENSIONAHA.107.107607"},{"key":"10.1016\/j.ejogrb.2026.115048_b0070","doi-asserted-by":"crossref","unstructured":"JGL Ramos, N Sass, SMH Costa, Preeclampsia: definitions of hypertensive states during pregnancy pathophysiological foundations, UpToDate, vol. 39, pp. 496\u2013512, 2017, [Online]. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/28793357\/.","DOI":"10.1055\/s-0037-1604471"},{"key":"10.1016\/j.ejogrb.2026.115048_b0075","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2005-0078","article-title":"Molecular evidence of placental hypoxia in preeclampsia","author":"Soleymanlou","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2026.115048_b0080","doi-asserted-by":"crossref","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction hypertension, and proteinuria in preeclampsia","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejogrb.2026.115048_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.placenta.2008.11.009","article-title":"The two stage model of preeclampsia: variations on the theme","author":"Roberts","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.ejogrb.2026.115048_b0090","article-title":"Biochemical markers for prediction of preclampsia: review of the literature","author":"Monte","year":"2011","journal-title":"J Prenat Med"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115048_b0095","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/CIRCULATIONAHA.109.895458","article-title":"Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension","volume":"122","author":"Noori","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2026.115048_b0100","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V87.8.3336.bloodjournal8783336","article-title":"Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1","author":"Barleon","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ejogrb.2026.115048_b0105","doi-asserted-by":"crossref","DOI":"10.1210\/mend.13.4.0265","article-title":"Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity","author":"He","year":"1999","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9440(10)62567-9","article-title":"Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome","author":"Zhou","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0115","doi-asserted-by":"crossref","DOI":"10.1161\/01.RES.0000147365.86159.f5","article-title":"Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia","author":"Ahmad","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.ejogrb.2026.115048_b0120","doi-asserted-by":"crossref","DOI":"10.1620\/tjem.195.43","article-title":"Glomerular endothelial cells are maintained by vascular endothelial growth factor in the adult kidney","author":"Kitamoto","year":"2001","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.ejogrb.2026.115048_b0125","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.C300012200","article-title":"Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria","author":"Sugimoto","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejogrb.2026.115048_b0130","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa021491","article-title":"A randomized trial of bevacizumab, an anti\u2013vascular endothelial growth factor antibody, for metastatic renal cancer","author":"Yang","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2026.115048_b0135","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.63.10.1475","article-title":"Reversible posterior leukoencephalopathy syndrome after bevacizumab\/FOLFIRI regimen for metastatic colon cancer","author":"Allen","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0140","doi-asserted-by":"crossref","DOI":"10.1291\/hypres.28.727","article-title":"Establishing reference values for both total soluble Fms-like tyrosine kinase 1 and free placental growth factor in pregnant women","author":"Hirashima","year":"2005","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ejogrb.2026.115048_b0145","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2026.115048_b0150","doi-asserted-by":"crossref","unstructured":"M Widmer, J Villar, A Benigni, A Conde-Agudelo, SA Karumanchi, M Lindheimer, Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review, 2007. doi: 10.1097\/01.AOG.0000249609.04831.7c.","DOI":"10.1097\/01.AOG.0000249609.04831.7c"},{"key":"10.1016\/j.ejogrb.2026.115048_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(18)47298-5","article-title":"Placenta growth factor: potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1\/KDR","author":"Park","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejogrb.2026.115048_b0160","doi-asserted-by":"crossref","unstructured":"M Autiero, A Luttun, M Tjwa, P Carmeliet, Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders, 2003. doi: 10.1046\/j.1538-7836.2003.00263.x.","DOI":"10.1046\/j.1538-7836.2003.00263.x"},{"key":"10.1016\/j.ejogrb.2026.115048_b0165","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.88.20.9267","article-title":"Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor","author":"Maglione","year":"1991","journal-title":"PNAS"},{"key":"10.1016\/j.ejogrb.2026.115048_b0170","article-title":"Expression and function of placenta growth factor","author":"Torry","year":"2003","journal-title":"Implications for abnormal placentation"},{"key":"10.1016\/j.ejogrb.2026.115048_b0175","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.134.2.1276","article-title":"Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies","author":"Quackenbush","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(19)38892-1","article-title":"Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells","author":"Gougos","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejogrb.2026.115048_b0185","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.274.2.584","article-title":"Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-\u03b2 superfamily","author":"Barbara","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejogrb.2026.115048_b0190","doi-asserted-by":"crossref","unstructured":"FC Luft, Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a pre-eclampsia molecule, 2006. doi: 10.1093\/ndt\/gfl439.","DOI":"10.1093\/ndt\/gfl439"},{"key":"10.1016\/j.ejogrb.2026.115048_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(18)41732-2","article-title":"Endoglin is a component of the transforming growth factor-\u03b2 receptor system in human endothelial cells","author":"Cheifetz","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejogrb.2026.115048_b0200","doi-asserted-by":"crossref","DOI":"10.1093\/intimm\/4.1.83","article-title":"Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts","author":"Gougos","year":"1992","journal-title":"Int Immunol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0205","doi-asserted-by":"crossref","DOI":"10.1002\/eji.1830220216","article-title":"Regulated expression on human macrophages of endoglin, an Arg\u2010Gly\u2010Asp\u2010containing surface antigen","author":"Lastres","year":"1992","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0210","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.202614899","article-title":"Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells","author":"Chen","year":"2002","journal-title":"PNAS"},{"key":"10.1016\/j.ejogrb.2026.115048_b0215","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2006-2349","article-title":"Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia","author":"Masuyama","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2026.115048_b0220","doi-asserted-by":"crossref","unstructured":"VA Reznik, DO Ivanov, NN Ruhlyada, NI Tapilskaya, IA Ershov, The importance of antiangiogenic substances endoglin and sFLT-1, as well as endogenous digitalis-like factor marinobufagenin in the pathogenesis of preeclampsia, Pediatr. (St. Petersburg), vol. 11, no. 1, pp. 5\u201312, 2020, doi: 10.17816\/ped1115-12.","DOI":"10.17816\/PED1115-12"},{"issue":"3","key":"10.1016\/j.ejogrb.2026.115048_b0225","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1479-828X.1989.tb01751.x","article-title":"Serum uric acid levels in normal pregnancy","volume":"29","author":"Carter","year":"1989","journal-title":"Aust New Zeal J Obstet Gynaecol"},{"issue":"5851","key":"10.1016\/j.ejogrb.2026.115048_b0230","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/bmj.1.5851.449","article-title":"Effect of oestrogen therapy on plasma and urinary levels of uric acid","volume":"1","author":"Nicholls","year":"1973","journal-title":"Br Med J"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115048_b0235","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/14767058.2018.1484093","article-title":"Maternal serum uric acid levels in pregnancy and fetal growth","volume":"33","author":"Zhou","year":"2020","journal-title":"J Matern Neonatal Med"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115048_b0240","article-title":"Association between serum uric acid levels and perinatal outcome in women with preeclampsia","volume":"2021","author":"Ugwuanyi","year":"2021","journal-title":"Obstet Gynecol Int"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115048_b0245","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0002-9378(96)70410-6","article-title":"Hyperuricemia and xanthine oxidase in preeclampsia, revisited","volume":"174","author":"Many","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejogrb.2026.115048_b0250","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000052918","article-title":"Relation between serum uric acid and plasma adenosine levels in women with preeclampsia","volume":"51","author":"Suzuki","year":"2001","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115048_b0255","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0002-9440(10)64733-5","article-title":"Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia","volume":"156","author":"Many","year":"2000","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.ejogrb.2026.115048_b0260","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","article-title":"Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis","volume":"78","author":"Ames","year":"1981","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ejogrb.2026.115048_b0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clicom.2022.03.003","article-title":"Potential role of uric acid to activate NLRP3 inflammasome triggering endothelial dysfunction in preeclampsia","volume":"2","author":"Nunes","year":"2022","journal-title":"Clin Immunol Commun"},{"issue":"12","key":"10.1016\/j.ejogrb.2026.115048_b0270","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nrneph.2010.125","article-title":"Could uric acid have a pathogenic role in pre-eclampsia?","volume":"6","author":"Martin","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115048_b0275","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2174\/1573402114666181112141953","article-title":"Maternal serum uric acid as a predictor of severity of hypertensive disorders of pregnancy: a prospective cohort study","volume":"15","author":"Kumar","year":"2019","journal-title":"Curr Hypertens Rev"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115048_b0280","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ijgo.12697","article-title":"Maternal serum uric acid concentration and pregnancy outcomes in women with pre\u2010eclampsia\/eclampsia","volume":"144","author":"Le","year":"2019","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115048_b0285","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","article-title":"Nitric oxide: physiology, pathophysiology, and pharmacology","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10.1016\/j.ejogrb.2026.115048_b0290","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tem.2009.03.005","article-title":"eNOS, metabolic syndrome and cardiovascular disease","volume":"20","author":"Huang","year":"2009","journal-title":"Trends Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ejogrb.2026.115048_b0295","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","article-title":"Metformin: historical overview","volume":"60","author":"Bailey","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejogrb.2026.115048_b0300","doi-asserted-by":"crossref","DOI":"10.1002\/pdi.606","article-title":"Metformin: its botanical background","author":"Bailey","year":"2004","journal-title":"Pract Diabetes Int"},{"key":"10.1016\/j.ejogrb.2026.115048_b0305","doi-asserted-by":"crossref","DOI":"10.1177\/1478271520053503010","article-title":"Goat\u2019s rue - French lilac - italian fitch - spanish sainfoin: gallega officinalis and metformin: the Edinburgh connection","author":"Hadden","year":"2005","journal-title":"J R Coll Physicians Edinb"},{"key":"10.1016\/j.ejogrb.2026.115048_b0310","doi-asserted-by":"crossref","unstructured":"\u201c9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetesd2019,\u201d Diabetes Care, 2019, doi: 10.2337\/dc19-S009.","DOI":"10.2337\/dc19-S009"},{"key":"10.1016\/j.ejogrb.2026.115048_b0315","doi-asserted-by":"crossref","unstructured":"LA Witters, The blooming of the French lilac, 2001. doi: 10.1172\/JCI14178.","DOI":"10.1172\/JCI14178"},{"key":"10.1016\/j.ejogrb.2026.115048_b0320","article-title":"Combination glucose-lowering therapy plans in T2DM","author":"Blonde","year":"2018","journal-title":"Case-Based Considerations"},{"key":"10.1016\/j.ejogrb.2026.115048_b0325","doi-asserted-by":"crossref","unstructured":"S Gandini et al., Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders, 2014. doi: 10.1158\/1940-6207.CAPR-13-0424.","DOI":"10.1158\/1940-6207.CAPR-13-0424"},{"key":"10.1016\/j.ejogrb.2026.115048_b0330","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-med-062613-093128","article-title":"Metformin in cancer treatment and prevention","author":"Morales","year":"2015","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ejogrb.2026.115048_b0335","doi-asserted-by":"crossref","DOI":"10.1111\/j.1463-1326.2010.01349.x","article-title":"Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials, Diabetes","author":"Lamanna","year":"2011","journal-title":"Obes Metab"},{"key":"10.1016\/j.ejogrb.2026.115048_b0340","doi-asserted-by":"crossref","unstructured":"A Bhat, G Sebastiani, M Bhat, Systematic review: preventive and therapeutic applications of metformin in liver disease, 2015. doi: 10.4254\/wjh.v7.i12.1652.","DOI":"10.4254\/wjh.v7.i12.1652"},{"key":"10.1016\/j.ejogrb.2026.115048_b0345","doi-asserted-by":"crossref","DOI":"10.1111\/dom.13362","article-title":"Metformin targets brown adipose tissue in vivo and reduces oxygen consumption in vitro, Diabetes","author":"Breining","year":"2018","journal-title":"Obes Metab"},{"key":"10.1016\/j.ejogrb.2026.115048_b0350","doi-asserted-by":"crossref","unstructured":"C Patrone, O Eriksson, D Lindholm, Diabetes drugs and neurological disorders: new views and therapeutic possibilities, 2014. doi: 10.1016\/S2213-8587(13)70125-6.","DOI":"10.1016\/S2213-8587(13)70125-6"},{"key":"10.1016\/j.ejogrb.2026.115048_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2018.01.027","article-title":"Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder","author":"Neven","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejogrb.2026.115048_b0360","doi-asserted-by":"crossref","unstructured":"MJ Dresser, MK Leabman, KM Giacomini, Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters, 2001. doi: 10.1002\/1520-6017(200104)90:4397::AID-JPS10003.0.CO;2-D.","DOI":"10.1002\/1520-6017(200104)90:4<397::AID-JPS1000>3.3.CO;2-4"},{"key":"10.1016\/j.ejogrb.2026.115048_b0365","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.107.015495","article-title":"Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine","author":"Zhou","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ejogrb.2026.115048_b0370","doi-asserted-by":"crossref","unstructured":"AJ Scheen, Clinical pharmacokinetics of metformin, 1996. doi: 10.2165\/00003088-199630050-00003.","DOI":"10.2165\/00003088-199630050-00003"},{"key":"10.1016\/j.ejogrb.2026.115048_b0375","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2125.1981.tb01206.x","article-title":"Metformin kinetics in healthy subjects and in patients with diabetes mellitus","author":"Tucker","year":"1981","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0380","article-title":"Function and control of human invasive trophoblast subtypes","author":"Velicky","year":"2016","journal-title":"Intrinsic vs maternal control"},{"key":"10.1016\/j.ejogrb.2026.115048_b0385","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12339","article-title":"Glucose and metformin modulate human first trimester trophoblast function: a model and potential therapy for diabetes-associated uteroplacental insufficiency","author":"Han","year":"2015","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054153","article-title":"Gestation dependant changes in angiogenic factors and their associations with fetal growth measures in normotensive pregnancy","author":"Sundrani","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejogrb.2026.115048_b0395","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11112111","article-title":"Markers of endothelial dysfunction are attenuated by resveratrol in preeclampsia","author":"Bueno-Pereira","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejogrb.2026.115048_b0400","doi-asserted-by":"crossref","unstructured":"S Rana, SD Burke, SA Karumanchi, Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders, 2022. doi: 10.1016\/j.ajog.2020.10.022.","DOI":"10.1016\/j.ajog.2020.10.022"},{"key":"10.1016\/j.ejogrb.2026.115048_b0405","doi-asserted-by":"crossref","unstructured":"C Han, P Huang, M Lyu, J Dong, Oxidative stress and preeclampsia-associated prothrombotic state, 2020. doi: 10.3390\/antiox9111139.","DOI":"10.3390\/antiox9111139"},{"key":"10.1016\/j.ejogrb.2026.115048_b0410","doi-asserted-by":"crossref","DOI":"10.1007\/s40292-023-00608-y","article-title":"First trimester CD93 as a novel marker of preeclampsia and its complications: a pilot study","author":"Piani","year":"2023","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.ejogrb.2026.115048_b0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.preghy.2020.06.008","article-title":"Therapeutic doses of metformin do not have impact on angiogenesis in presence of sera from pre-eclamptic, IUGR and healthy pregnancies","author":"Virtanen","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ejogrb.2026.115048_b0420","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.575390","article-title":"Metformin ameliorates gestational diabetes mellitus-induced endothelial dysfunction via downregulation of p65 and upregulation of Nrf2","author":"Sun","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0425","doi-asserted-by":"crossref","DOI":"10.1177\/1758835918770984","article-title":"Metformin prevents nerve growth factor-dependent proliferative and proangiogenic effects in epithelial ovarian cancer cells and endothelial cells","author":"Garrido","year":"2018","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0430","doi-asserted-by":"crossref","unstructured":"Z Ungvari et al., Endothelial dysfunction and angiogenesis impairment in the ageing vasculature, 2018. doi: 10.1038\/s41569-018-0030-z.","DOI":"10.1038\/s41569-018-0030-z"},{"key":"10.1016\/j.ejogrb.2026.115048_b0435","doi-asserted-by":"crossref","DOI":"10.1161\/01.ATV.0000205607.98538.9a","article-title":"Granulocyte colony-stimulating factor-mobilized circulating c-Kit+\/Flk-1+ progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury","author":"Takamiya","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0440","doi-asserted-by":"crossref","DOI":"10.1152\/ajplung.00200.2012","article-title":"AMP kinase activation improves angiogenesis in pulmonary artery endothelial cells with in utero pulmonary hypertension","author":"Teng","year":"2013","journal-title":"Am J Physiol - Lung Cell Mol Physiol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0445","doi-asserted-by":"crossref","DOI":"10.1111\/ejn.12556","article-title":"Chronic metformin treatment improves post-stroke angiogenesis and recovery after experimental stroke","author":"Venna","year":"2014","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.ejogrb.2026.115048_b0450","doi-asserted-by":"crossref","DOI":"10.1161\/01.HYP.0000221429.94591.72","article-title":"Metformin inhibits cytokine-induced nuclear factor \u03baB activation via AMP-activated protein kinase activation in vascular endothelial cells","author":"Hattori","year":"2006","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115048_b0455","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/ATVBAHA.113.301938","article-title":"Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5\u2032 adenosine monophosphate\u2013activated protein kinase\u2013peroxisome proliferator\u2013activated receptor \u03b4 pathway","volume":"34","author":"Cheang","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105693","article-title":"Metformin exhibits its therapeutic effect in the treatment of pre-eclampsia via modulating the Met\/H19\/miR-148a-5p\/P28 and Met\/H19\/miR-216-3p\/EBI3 signaling pathways","volume":"74","author":"Shu","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2018.11.032","article-title":"Direct toxicity of insulin on the human placenta and protection by metformin","author":"Vega","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2026.115048_b0470","doi-asserted-by":"crossref","unstructured":"MB Ten\u00f3rio, RC Ferreira, FA Moura, NB Bueno, ACM De Oliveira, MOF Goulart, Cross-talk between oxidative stress and inflammation in preeclampsia, 2019. doi: 10.1155\/2019\/8238727.","DOI":"10.1155\/2019\/8238727"},{"key":"10.1016\/j.ejogrb.2026.115048_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(15)00219-3","article-title":"Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial","author":"Chiswick","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0480","doi-asserted-by":"crossref","DOI":"10.1111\/fcp.12501","article-title":"Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia","author":"Hu","year":"2019","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0485","doi-asserted-by":"crossref","unstructured":"CR Triggle, H Ding, Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium, 2017. doi: 10.1111\/apha.12644.","DOI":"10.1111\/apha.12644"},{"key":"10.1016\/j.ejogrb.2026.115048_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/S0301-2115(96)02647-4","article-title":"Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in preeclampsia","author":"Austgulen","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0495","doi-asserted-by":"crossref","DOI":"10.1080\/jmf.12.1.19.27","article-title":"Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia","author":"Chaiworapongsa","year":"2002","journal-title":"J Matern Neonatal Med"},{"key":"10.1016\/j.ejogrb.2026.115048_b0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.12.019","article-title":"Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction","author":"Brownfoot","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188845","article-title":"Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction \u2013 implications for treating preeclampsia","author":"Kaitu\u2019u-Lino","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejogrb.2026.115048_b0510","article-title":"Endoplasmic reticulum stress","author":"Xu","year":"2005","journal-title":"Cell life and death decisions"},{"key":"10.1016\/j.ejogrb.2026.115048_b0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.placenta.2008.11.003","article-title":"Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia","author":"Burton","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.ejogrb.2026.115048_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.placenta.2016.04.001","article-title":"Mitochondrial \u2013 endoplasmic reticulum interactions in the trophoblast: stress and senescence","author":"Burton","year":"2017","journal-title":"Placenta"},{"key":"10.1016\/j.ejogrb.2026.115048_b0525","article-title":"The roles of metformin and pravastatin on placental endoplasmic reticulum stress and placental growth factor in human villous-like trophoblastic BeWo cells","author":"Suzuki","year":"2018","journal-title":"Sapporo Med J"},{"key":"10.1016\/j.ejogrb.2026.115048_b0530","doi-asserted-by":"crossref","DOI":"10.1053\/plac.2002.0867","article-title":"Expression and activity of matrix metalloproteinase 2 and 9 in human trophoblasts","author":"Isaka","year":"2003","journal-title":"Placenta"},{"key":"10.1016\/j.ejogrb.2026.115048_b0535","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6547019","article-title":"Effect of metformin on a preeclampsia-like mouse model induced by high-fat diet","volume":"2019","author":"Wang","year":"2019","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ejogrb.2026.115048_b0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2005.06.019","article-title":"Statins prevent NF-\u03baB transactivation independently of the IKK-pathway in human endothelial cells","author":"H\u00f6lschermann","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejogrb.2026.115048_b0545","doi-asserted-by":"crossref","unstructured":"N Koundouros, G Poulogiannis, Phosphoinositide 3-kinase\/Akt signaling and redox metabolism in cancer, 2018. doi: 10.3389\/fonc.2018.00160.","DOI":"10.3389\/fonc.2018.00160"},{"key":"10.1016\/j.ejogrb.2026.115048_b0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.placenta.2023.01.001","article-title":"Sulfasalazine for the treatment of preeclampsia in a nitric oxide synthase antagonist mouse model","author":"Binder","year":"2023","journal-title":"Placenta"},{"key":"10.1016\/j.ejogrb.2026.115048_b0555","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.979300","article-title":"Effect of sulfasalazine on endothelium-dependent vascular response by the activation of Nrf2 signalling pathway","author":"Sonmez","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0560","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.4297","article-title":"RNAi modulation of placental sFLT1 for the treatment of preeclampsia","author":"Turanov","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124684","article-title":"First-trimester maternal serum levels of sFLT1, PGF and ADMA predict preeclampsia","author":"Bian","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejogrb.2026.115048_b0570","doi-asserted-by":"crossref","DOI":"10.3760\/cma.j.issn.0366-6999.20132781","article-title":"Metformin inhibits nuclear factor-\u03baB activation and inflammatory cytokines expression induced by high glucose via adenosine monophosphate-activated protein kinase activation in rat glomerular mesangial cells in vitro","author":"Gu","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ejogrb.2026.115048_b0575","doi-asserted-by":"crossref","unstructured":"AJ Scheen, N Esser, N Paquot, Antidiabetic agents: potential anti-inflammatory activity beyond glucose control, 2015. doi: 10.1016\/j.diabet.2015.02.003.","DOI":"10.1016\/j.diabet.2015.02.003"},{"key":"10.1016\/j.ejogrb.2026.115048_b0580","doi-asserted-by":"crossref","unstructured":"A Saenz, I Fernandez-Esteban, A Mataix, MA Segura, M Roqu\u00e9 i Figuls, D Moher, Metformin monotherapy for type 2 diabetes mellitus, 2005. doi: 10.1002\/14651858.CD002966.pub3.","DOI":"10.1002\/14651858.CD002966.pub3"},{"key":"10.1016\/j.ejogrb.2026.115048_b0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2003.07.020","article-title":"Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus","author":"Abbasi","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.ejogrb.2026.115048_b0590","article-title":"Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance","author":"Kraemer De Aguiar","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejogrb.2026.115048_b0595","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy","author":"Libby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2026.115048_b0600","doi-asserted-by":"crossref","DOI":"10.1111\/j.1476-5381.2011.01230.x","article-title":"Metformin restores endothelial function in aorta of diabetic rats","author":"Sena","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2016.04.018","article-title":"Metformin attenuates fluctuating glucose-induced endothelial dysfunction through enhancing GTPCH1-mediated eNOS recoupling and inhibiting NADPH oxidase","author":"An","year":"2016","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.ejogrb.2026.115048_b0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2010.04.017","article-title":"Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway","author":"Hou","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejogrb.2026.115048_b0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2015.07.118","article-title":"Metformin decreases growth of pancreatic cancer cells by decreasing reactive oxygen species: role of NOX4","author":"Cheng","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejogrb.2026.115048_b0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.placenta.2023.10.003","article-title":"Protective role of metformin in preeclampsia via the regulation of NF-\u03baB\/sFlt-1 and Nrf2\/HO-1 signaling pathways by activating AMPK","author":"He","year":"2023","journal-title":"Placenta"},{"key":"10.1016\/j.ejogrb.2026.115048_b0625","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22368","article-title":"Metformin in contrast to berberine reversed arsenic-induced oxidative stress in mitochondria from rat pancreas probably via Sirt3-dependent pathway","author":"Javadipour","year":"2019","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0630","article-title":"SIRT3-AMP-activated protein kinase activation by nitrite and metformin improves hyperglycemia and normalizes pulmonary hypertension associated with heart failure with preserved ejection fraction","author":"Lai","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2026.115048_b0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111921","article-title":"L-ergothioneine and its combination with metformin attenuates renal dysfunction in type-2 diabetic rat model by activating Nrf2 antioxidant pathway","author":"Dare","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ejogrb.2026.115048_b0640","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.preghy.2018.08.287","article-title":"200. Clinical trial of metformin to treat preterm preeclampsia: pharmacokinetics and biomarker studies","volume":"13","author":"Tong","year":"2018","journal-title":"Pregnancy Hypertens"},{"issue":"6","key":"10.1016\/j.ejogrb.2026.115048_b0645","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-082880","article-title":"Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial","volume":"14","author":"Cluver","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejogrb.2026.115048_b0650","doi-asserted-by":"crossref","unstructured":"CA Cluver et al., Metformin to treat preterm pre-eclampsia: a randomised, double-blind, placebo-controlled trial, 2021.","DOI":"10.1136\/bmj.n2103"},{"key":"10.1016\/j.ejogrb.2026.115048_b0655","doi-asserted-by":"crossref","DOI":"10.1161\/01.ATV.0000201938.78044.75","article-title":"Metformin inhibits proinflammatory responses and nuclear factor-\u03baB in human vascular wall cells","author":"Isoda","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0660","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1222051110","article-title":"AMPK\u03b12 exerts its anti-inflammatory effects through PARP-1 and Bcl-6","author":"Gongol","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.ejogrb.2026.115048_b0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2005.01.029","article-title":"Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells","author":"Ouslimani","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.ejogrb.2026.115048_b0670","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-016-0344-2","article-title":"Metformin improves the angiogenic potential of human CD34+ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction","author":"Bakhashab","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0675","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-016-0408-3","article-title":"Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK\/eNOS pathway in diabetic mice","author":"Yu","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0680","doi-asserted-by":"crossref","unstructured":"JM Roberts, Endothelial dysfunction in preeclampsia, in Seminars in reproductive endocrinology, Copyright\u00a9 1998 by Thieme Medical Publishers, Inc., 1998, pp. 5\u201315.","DOI":"10.1055\/s-2007-1016248"},{"key":"10.1016\/j.ejogrb.2026.115048_b0685","doi-asserted-by":"crossref","DOI":"10.1111\/bph.12496","article-title":"Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1","author":"Arunachalam","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0690","unstructured":"K. M., D. H., and T. C.R., Metformin: an old drug for the treatment of diabetes but a new drug for the protection of the endothelium, Med Princ Pract, 2015."},{"key":"10.1016\/j.ejogrb.2026.115048_b0695","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2840-12-175","article-title":"Effects of two weeks of metformin treatment on whole-body glycocalyx barrier properties in db\/db mice","author":"Eskens","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ejogrb.2026.115048_b0700","doi-asserted-by":"crossref","unstructured":"DL Rolnik, KH Nicolaides, LC Poon, Prevention of preeclampsia with aspirin, 2022. doi: 10.1016\/j.ajog.2020.08.045.","DOI":"10.1016\/j.ajog.2020.08.045"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526001144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526001144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:08:41Z","timestamp":1782774521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211526001144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":140,"alternative-id":["S0301211526001144"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115048","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin: An emerging therapeutic approach for prevention and treatment of preeclampsia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115048"}}